According to this press release:
"With all this new knowledge, the need to share information is paramount, now more than ever before," says Camacho, the study's senior author. "We, as clinicians and researchers, have a tremendous responsibility to not only investigate and discover new agents, but also to disseminate our discoveries - good and bad - to the medical community at large, to ensure the safety and well-being of our patients."
Whileare another place to disseminate the information, Comacho, who is assistant professor of medicine in M. D. Anderson's Phase I Clinical Trials Program, says often these results are preliminary and subject to change after final analysis. Therefore, publishing in peer-reviewed scientific journals remains the "gold-standard" for sharing medical information.